These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30290461)

  • 21. The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.
    MacKenzie EM; Odontiadis J; Le Mellédo JM; Prior TI; Baker GB
    Cell Mol Neurobiol; 2007 Aug; 27(5):541-74. PubMed ID: 17235696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
    Devaud LL; Purdy RH; Finn DA; Morrow AL
    J Pharmacol Exp Ther; 1996 Aug; 278(2):510-7. PubMed ID: 8768698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of allopregnanolone in depression and anxiety.
    Schüle C; Nothdurfter C; Rupprecht R
    Prog Neurobiol; 2014 Feb; 113():79-87. PubMed ID: 24215796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of sleep deprivation on neuroactive steroids in major depression.
    Schüle C; di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2003 Mar; 28(3):577-81. PubMed ID: 12629540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.
    Porcu P; Barron AM; Frye CA; Walf AA; Yang SY; He XY; Morrow AL; Panzica GC; Melcangi RC
    J Neuroendocrinol; 2016 Feb; 28(2):12351. PubMed ID: 26681259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F; Perini G; Serra M; Pisu MG; Zanone S; Toffanin T; Milleri S; Garcia CS; Biggio G
    Psychoneuroendocrinology; 2013 Oct; 38(10):2234-42. PubMed ID: 23702252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurosteroids and neuroactive drugs in mental disorders.
    Pisu MG; Serra M
    Life Sci; 2004 May; 74(26):3181-97. PubMed ID: 15094320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and neuroactive steroids.
    Rapkin AJ; Biggio G; Concas A
    Pharmacol Biochem Behav; 2006 Aug; 84(4):628-34. PubMed ID: 16854457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes.
    Rapkin AJ; Morgan M; Sogliano C; Biggio G; Concas A
    Fertil Steril; 2006 May; 85(5):1371-8. PubMed ID: 16580672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.
    Rupprecht R; Holsboer F
    Trends Neurosci; 1999 Sep; 22(9):410-6. PubMed ID: 10441302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women.
    Amin Z; Mason GF; Cavus I; Krystal JH; Rothman DL; Epperson CN
    Pharmacol Biochem Behav; 2006 Aug; 84(4):635-43. PubMed ID: 16860856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants.
    Kaufman Y; Carlini SV; Deligiannidis KM
    Ther Adv Psychopharmacol; 2022; 12():20451253211065859. PubMed ID: 35111296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels.
    Espallergues J; Mamiya T; Vallée M; Koseki T; Nabeshima T; Temsamani J; Laruelle C; Maurice T
    Neuropharmacology; 2012 Jan; 62(1):492-502. PubMed ID: 21945799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.
    Zwanzger P; Rupprecht R
    J Psychiatry Neurosci; 2005 May; 30(3):167-75. PubMed ID: 15944741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
    Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
    Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosteroids: mechanistic considerations and clinical prospects.
    Maguire JL; Mennerick S
    Neuropsychopharmacology; 2024 Jan; 49(1):73-82. PubMed ID: 37369775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside.
    Strous RD; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):155-69. PubMed ID: 16257183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroactive steroids and PTSD treatment.
    Rasmusson AM; Marx CE; Pineles SL; Locci A; Scioli-Salter ER; Nillni YI; Liang JJ; Pinna G
    Neurosci Lett; 2017 May; 649():156-163. PubMed ID: 28215878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.